Related by context. All words. (Click for frequent words.) 76 phase IIa clinical 75 phase IIb clinical 75 Phase Ib 74 Phase III clinical 74 Phase IIa clinical 74 Phase 2b trial 74 Phase IIb trial 74 Phase IIIb clinical 74 phase IIa 74 Phase III confirmatory 73 Phase 1b clinical 73 Phase 2a trial 73 Phase 2b clinical 73 Phase Ib study 73 phase IIb 72 Phase Ib clinical 72 Phase #b/#a 72 dose escalation Phase 72 Phase 2a clinical 72 pivotal Phase III 72 Phase IIb trials 72 Phase IIb clinical 71 Zenvia ™ 71 Phase #b/#a clinical 71 registrational 71 Phase 2b study 71 Phase 1b trial 71 Phase IIa trial 71 IIa trial 70 elotuzumab 70 Phase IIb III 70 Dacogen injection 70 deforolimus 70 Phase IIb 70 Phase IIa 70 Phase III pivotal 70 alvespimycin 70 MAA submission 70 BLA filing 70 Phase 1b 69 phase IIb trial 69 JAK inhibitor 69 Phase III 69 registrational trial 69 Phase IIa trials 69 Phase IIIb 69 pivotal bioequivalence 69 SUCCEED trial 69 placebo controlled clinical 69 Phase Ib clinical trials 69 Phase 1a clinical 69 dextromethorphan quinidine 69 multicenter Phase 69 Phase #/#a 68 AeroLEF TM 68 confirmatory Phase 3 68 phase Ib 68 ruxolitinib 68 Phase 2b kidney transplant 68 Phase #b/#a trial 68 Phase IIB 68 Phase 2a 68 phase 2a 68 Phase IIb clinical trials 68 Phase Ib II 68 oral ridaforolimus 68 AQ4N 68 multicenter Phase II 68 Phase 1a 68 GALNS 68 randomized Phase IIb 68 TOCOSOL Paclitaxel 68 phase Ib clinical 68 cannabinor 68 BRIM2 67 ENRICH trial 67 phase IIb III 67 rALLy clinical trial 67 octreotide implant 67 IL# PE#QQR 67 Phase Ib IIa 67 Phase III clinical trials 67 lorvotuzumab mertansine 67 IMA# 67 Troxatyl 67 PEG PAL 67 phase IIIb 67 TELINTRA 67 MIST II 67 Phase 2b 67 Phase IIa clinical trials 67 phase IIb study 67 HGS# 67 incyclinide 67 dose escalation trial 67 PFO migraine 67 MEND CABG II 67 dose escalation clinical 67 CB2 selective receptor agonist 67 Allovectin 7 67 Zerenex 67 CLIRS trial 67 Phase 2a clinical trials 66 OvaRex ® MAb 66 alvimopan 66 lomitapide 66 initiate Phase Ib 66 oral deforolimus 66 tezampanel NGX# 66 opioid induced bowel dysfunction 66 multicenter randomized placebo controlled 66 tanespimycin 66 PREOS 66 Phase 2b clinical trials 66 APEX PD 66 pharmacokinetic PK study 66 subcutaneous formulation 66 PRT# 66 hypoxia activated prodrug 66 placebo controlled Phase 66 Phase Ia 66 vosaroxin 66 Phase III trials 66 ASONEP 66 AzaSite Plus 66 PDE4 inhibitor 66 Plicera 66 pseudobulbar affect PBA 66 Cloretazine R VNP#M 66 IND submission 66 FOLOTYN ® 66 BRIM3 66 oral prodrug 66 initiate Phase 1b 66 initiate Phase IIb 66 initiate Phase 2b 66 Zenvia TM 66 ofatumumab 65 Panzem R NCD 65 PRECISE Trial 65 dirucotide 65 CEQ# 65 Alzhemed TM 65 eniluracil 65 sNDA submission 65 bicifadine 65 HGS ETR1 65 Neurodex 65 NGX# 65 docetaxel Taxotere R 65 velafermin 65 selective androgen receptor modulator 65 Multiple Ascending Dose 65 ITAX 65 pivotal Phase 65 randomized Phase 2b 65 placebo controlled Phase III 65 INCB# [001] 65 Phase III randomized controlled 65 multiple ascending dose 65 unblinding 65 forodesine 65 Dyloject TM 65 Androxal TM 65 reslizumab 65 tolevamer 65 Amigal 65 randomized multicenter 65 Anturol 65 Zenvia 65 evaluating satraplatin 65 Cloretazine ® 65 Phenoptin 65 Corlux 65 Phase III multicenter 65 Omigard 65 oral methylnaltrexone 65 EDEMA3 65 randomized Phase III 65 Pimavanserin 65 candidate AQ4N 65 midstage trials 65 BLA submission 65 CR# vcMMAE 65 TELCYTA 65 NP2 Enkephalin 65 viral kinetic 65 TMC# C# 65 GLP toxicology studies 65 huN# DM1 65 PREOS R 65 ENDEAVOR IV 65 Phase III placebo controlled 65 zileuton CR 64 Phase lll 64 ularitide 64 Zelrix 64 ILLUMINATE 64 Fodosine 64 Personalized Immunotherapy 64 RSD# oral 64 multicentre randomized 64 PXD# 64 acyclovir Lauriad R 64 NEBIDO 64 ELACYT 64 StemEx 64 SILENOR TM 64 ATL# [001] 64 L BLP# 64 HuMax CD4 64 Annamycin 64 Microplasmin 64 clinical pharmacology studies 64 brivaracetam 64 ADVANCE PD 64 lintuzumab 64 Phase IIb kidney transplant 64 bardoxolone 64 Aryplase 64 glucokinase activator 64 budesonide foam 64 Phase 1b dose escalation 64 Bicifadine 64 PANVAC VF 64 EDEMA3 trial 64 ACCLAIM II 64 IND enabling 64 Urocidin 64 IIa clinical 64 generation purine nucleoside 64 celgosivir 64 Soliris TM eculizumab 64 Allovectin 7 R 64 MAXY alpha 64 blinded randomized placebo controlled 64 EOquin 64 huC# DM4 64 Fx #A 64 clinical trial 64 Ereska 64 Phase III psoriasis 64 orBec 64 pralatrexate 64 Phase II 64 initiate Phase IIa 64 Icatibant 64 LEP ETU 64 R#/MEM # 64 evaluating tivozanib 64 Archexin 64 dose escalation 64 confirmatory clinical 64 methylnaltrexone 64 Zenvia Phase III 64 AZILECT R 64 maribavir 64 Phase III Pivotal 64 PRIMO CABG 64 Azedra 64 multicenter clinical 64 volociximab 64 TRISENOX 64 oxymorphone ER 64 MEND CABG 64 Firazyr 64 PNP inhibitor 64 Rescula 64 GetGoal Phase III 64 Sulonex 64 PLK1 SNALP 64 PROMACTA 64 MNTX 64 SILENOR 64 SNT MC# 64 MAGE A3 ASCI 64 confirmatory pivotal 64 vidofludimus 64 CRMD# 64 SPARLON 64 Ketotransdel 63 European Sepsis Trial 63 Asentar 63 tezampanel 63 pradefovir 63 Fibrillex TM 63 Anturol TM 63 interferon beta 1b 63 omacetaxine mepesuccinate 63 Phase IIIb study 63 AZILECT ® 63 midstage clinical 63 Entereg R 63 interferon gamma 1b 63 CoFactor 63 tamibarotene 63 OvaRex R 63 initiated Phase Ib 63 MGd 63 PDX pralatrexate 63 axitinib 63 Amrubicin 63 Cellegesic 63 EOquin TM 63 EVIZON TM squalamine lactate 63 YONDELIS 63 evaluating Actimmune 63 randomized controlled Phase 63 VALOR trial 63 MOZOBIL 63 HCD# [002] 63 HGS ETR2 63 ocrelizumab 63 JZP 63 EFAPROXYN 63 ZYBRESTAT 63 RhuDex ® 63 Phase III Clinical Trial 63 ONCONASE R 63 tramiprosate Alzhemed TM 63 valopicitabine 63 INCB# [002] 63 Azedra TM 63 Stimuvax R 63 CA4P 63 inhaled liposomal ciprofloxacin 63 TACI Ig 63 StaphVAX 63 Pivotal Phase 63 elagolix 63 Cimzia TM 63 compound INCB# 63 IBS C 63 AIR CF1 63 PEG SN# 63 glufosfamide 63 vernakalant oral 63 AERx iDMS 63 aplindore 63 Iloperidone 63 tiapamil 63 rindopepimut 63 dose escalation study 63 dexanabinol 63 PF # [002] 63 PMA submission 63 budesonide MMX Phase III 63 Vascular Wrap 63 fostamatinib 63 PhosLo 63 PROVENGE ® 63 GAMMAGARD 63 Saforis 63 MONOVISC 63 otelixizumab 63 ARIKACE ™ 63 Marqibo 63 TG MV 63 urocortin 2 63 MERLIN TIMI 63 Surfaxin LS 63 histamine dihydrochloride 63 ZYBRESTAT fosbretabulin 63 induced macular edema 63 Phase III Trial 63 lumiliximab 63 prospective multicenter 63 IMGN# 63 TOLAMBA 63 Initiate Phase 63 dextofisopam 63 Phase 1b clinical trials 63 SYMMETRY trial 63 pertuzumab 63 Amoxicillin PULSYS Phase III 63 EGS# 63 nalbuphine ER 63 TLK# 63 ganetespib 63 Xcytrin R 63 PD LID 63 AEG# 63 VITAL Trial 63 CUSTOM III 63 tesmilifene 63 GED aPC 63 lucinactant 63 Entereg TM 63 RhuDex TM 62 LE SN# 62 NDA submission 62 masked placebo controlled 62 Stedivaze 62 PRX # 62 LEVADEX ™ 62 tramiprosate ALZHEMED TM 62 controlled multicenter 62 TBC# 62 ACAPODENE 62 GSK# [002] 62 HuMax EGFr 62 VNP#M 62 Glybera 62 double blinded placebo 62 Onalta ™ 62 PHX# 62 targeted radiotherapeutic 62 Proxinium TM 62 Telatinib 62 pharmacokinetic PK 62 FOLFOX6 chemotherapy regimen 62 DR Cysteamine 62 PRECISE trial 62 Vascular Wrap TM 62 Quinamed 62 ongoing Phase 1b 62 catheter occlusion 62 Myocet 62 Phase 2b randomized 62 ISTODAX 62 Pivotal Phase III 62 ospemifene 62 RH1 62 FavId 62 LibiGel Phase III 62 refractory metastatic colorectal cancer 62 Plenaxis R 62 CA9 SCAN 62 AZD# TC 62 ALN TTR# 62 Pivotal Trial 62 HuLuc# 62 visilizumab 62 synthetic retinoid 62 cangrelor 62 PrevOnco 62 NO# [002] 62 ponatinib 62 mertansine 62 XL# anticancer compounds 62 THALOMID 62 Besivance 62 placebo controlled randomized 62 SinuNase ™ 62 dimebon 62 romidepsin 62 clinical trials 62 Memryte 62 obatoclax 62 EndoTAG TM -1 62 candidate Zenvia 62 Hematide ™ 62 lintuzumab SGN 62 DDP# 62 Traficet EN 62 tecarfarin 62 MBP# [001] 62 randomized controlled multicenter 62 Allovectin 7 ® 62 Xanafide 62 Synavive 62 ROCKET AF 62 atacicept 62 SUTENT ® 62 single ascending dose 62 adipiplon 62 Desmoteplase 62 Phase #/#a clinical 62 enzastaurin 62 tremelimumab 62 neratinib 62 AIMM trial 62 Octreotide 62 desvenlafaxine succinate 62 teduglutide 62 pharmacodynamic PD 62 lurasidone 62 KRN# 62 controlled multicenter Phase 62 XL# XL# XL# 62 Ophena TM 62 cystinosis patients 62 mifamurtide 62 GOUT 62 KNS # 62 plasma kallikrein inhibitor 62 Prosaptide 62 multicenter 62 diabetic neuropathic pain 62 IMC #B 62 BAY #-# 62 Azixa 62 Aflibercept 62 NUVIGIL 62 Benlysta belimumab 62 Randomized Phase 62 multicenter Phase III 62 Dextofisopam 62 relapsed refractory multiple myeloma 62 investigational humanized monoclonal antibody 62 assessing T DM1 62 Velcade bortezomib 62 cetrorelix 62 LymphoStat B TM 62 sitaxsentan 62 Genz # 62 Oglemilast 62 Genasense ® oblimersen 62 inhaled AAT 62 OncoVEX GM CSF 62 opioid bowel dysfunction 62 Laquinimod 62 BEMA TM Fentanyl 62 Cethrin 62 canakinumab 62 Spiegelmer ® 62 MEK inhibitor RDEA# 62 Proellex TM 62 rALLy trial 62 sunitinib malate 62 Prestara 62 LE DT 62 riociguat 62 balsalazide tablet 62 SPIRIT FIRST 62 AIM HIGH 62 cetuximab Erbitux R 62 SPRYCEL ® 62 histone deacetylase HDAC inhibitor 62 prospective multicenter randomized 62 initiated Phase 1b 62 Capesaris 62 Zemplar Capsules 62 Ophena 61 PSMA ADC 61 alemtuzumab Campath 61 liprotamase 61 ANTEGREN 61 diarrhea predominant irritable 61 Evoltra ® 61 UPLYSO 61 ICA # 61 unique alkylating agent 61 TORISEL 61 Tyrima 61 Maximum Tolerated Dose MTD 61 multicenter placebo controlled 61 Tavocept 61 Targretin capsules 61 NDA resubmission 61 PFO closure 61 Canvaxin 61 dose escalation phase 61 AIR CF2 61 HspE7 61 ridaforolimus 61 Fentanyl Taifun 61 FOLOTYN 61 torezolid phosphate 61 UVIDEM 61 squalamine 61 QLT# 61 ofatumumab HuMax CD# 61 metastatic sarcomas 61 investigational antiplatelet agent 61 RhuDex 61 sapacitabine 61 HSP# inhibitor 61 HepeX B 61 including eniluracil ADH 61 Aurora kinase inhibitor 61 Iluvien ® 61 Shigamabs ® 61 Trofex 61 velafermin belinostat 61 EVIZON 61 Itopride 61 PEP# [003] 61 zileuton IV 61 mGluR2 positive 61 Prednisporin TM 61 nonclinical studies 61 Board DSMB 61 post herpetic neuralgia PHN 61 Viprinex TM 61 registrational studies 61 Zemiva ™ 61 ATryn R 61 faropenem 61 EmbraceAC 61 OncoGel 61 virus HCV protease inhibitor 61 Sym# 61 IIb clinical trial 61 pharmacokinetic studies 61 Nasdaq PGNX today 61 Cimzia ® certolizumab pegol 61 GSK# [001] 61 R#/MEM 61 Cinryze ™ 61 RezularTM 61 miconazole Lauriad ® 61 Clolar ® 61 Ixempra 61 PREGNANT Study 61 ABSORB trial 61 Junovan 61 ProSavin 61 amrubicin 61 Shigamabs R 61 Solzira 61 APEX AMI trial 61 iii GTx 61 daclizumab 61 HP Acthar Gel repository 61 Zavesca r 61 MEK inhibitor 61 LEUKINE 61 COSIRA trial 61 Amplimexon 61 Drug Eluting Stent System 61 label multicenter 61 baminercept 61 pomalidomide 61 Factor VIIa 61 Panzem R 61 Chemophase 61 Phase III TRIST 61 Cintredekin Besudotox 61 Augment Injectable 61 alogliptin 61 Telintra 61 Phase III HEAT 61 denufosol 61 DermaVir Patch 61 Ocrelizumab 61 tivozanib 61 COMFORT II 61 XmAb# 61 PDE# inhibitors 61 TRANSDUR Sufentanil 61 EchoCRT 61 BEMA Granisetron 61 TAXUS TM 61 Nuvion 61 Hedgehog antagonist 61 Phase III randomized 61 thorough QT 61 REG1 61 NVA# 61 Valtropin 61 VEGF Trap 61 blinatumomab 61 MINDSET 61 trial evaluating PRX# 61 dyskinesia PD LID 61 rNAPc2 61 generation rotary VAD 61 StemEx R 61 DPX Survivac 61 ocular formulation 61 SYCREST 61 AP# [003] 61 APPRAISE 61 Phase IIb Trial 61 Q#IR 61 Lucanix R 61 Genasense ® 61 polycythemia vera essential thrombocythemia 61 Initiates Phase II 61 Diamyd ® 61 bile duct tumor 61 receptor tyrosine kinase inhibitor 61 fosbretabulin 61 Marketing Authorization Application MAA 61 dirucotide MBP# 61 lymphoma CTCL 61 severe hypercholesterolemia 61 PS# [001] 61 TMC# [002] 61 Phase IIA 61 Viprinex 61 Ozarelix 61 Clonicel 61 Tamibarotene 61 Panzem ® 61 GEM OS2 61 PrevOnco ™ 61 GLPG# 61 fenretinide 61 registrational clinical 61 ApoB SNALP 61 URG# 61 SinuNase TM 61 Cloretazine 61 BCX# 61 intravenous methylnaltrexone 61 Initiated Phase 61 trastuzumab DM1 T DM1 61 CONBRIZA 61 Safinamide 61 Excellarate TM 61 rasagiline tablets 61 IMPACT IMmunotherapy 61 T Pred 61 posaconazole 61 AGILECT R 61 Actimmune ® 61 TOCOSOL Camptothecin 61 inhaled formulation 61 Kamada AAT 61 MBP# dirucotide 60 Lovaxin C 60 Tanespimycin 60 PNT# 60 Aplidin 60 entinostat 60 HQK 60 Bezielle 60 Medidur TM FA 60 beta 1a 60 SinuNase 60 dimebon latrepirdine 60 prokinetic agent 60 randomized multicentre 60 antibody MAb 60 IAP inhibitor 60 PHASE III 60 #D#C# 60 belinostat 60 sorafenib Nexavar 60 clofarabine 60 Urocidin TM 60 Virulizin R 60 personalized immunotherapy 60 Phase III registrational 60 vismodegib 60 refractory chronic lymphocytic 60 Triapine 60 Cannabinor 60 TYZEKA 60 II Clinical Trial 60 AMEVIVE 60 GRN# 60 ganaxolone 60 peginesatide 60 APTIVUS 60 CDP# 60 ONTAK 60 IoGen 60 LibiGel ® 60 mipomersen 60 bevasiranib 60 MGCD# [001] 60 cathepsin K inhibitor 60 Altastaph 60 placebo controlled 60 nab paclitaxel 60 MyVax R 60 ATryn ® 60 gemcitabine Gemzar ® 60 Ostarine 60 novel histone deacetylase 60 voreloxin 60 Gentamicin Surgical Implant 60 PIX# trial 60 LymphoStat B belimumab 60 Phase #/#a trial 60 BioSTAR R 60 telaprevir VX 60 intranasal formulation 60 TELINTRA R 60 double blinded randomized 60 Optiquel ™ 60 eprotirome 60 Voraxaze 60 WX UK1 60 rALLy 60 AGGRASTAT ® 60 Marketing Authorisation Application 60 HZT 60 Rezular 60 CCX# 60 MIRCERA 60 Neo Urinary Conduit 60 Mipomersen 60 Omigard TM 60 AZX# 60 CCR5 mAb 60 Glybera R 60 Locteron ® 60 Completes Patient Enrollment 60 metaglidasen 60 oral calcitonin 60 TEMSO 60 OFIRMEV 60 albinterferon alfa 2b 60 tasimelteon 60 ThermoDox R 60 GW# [003] 60 ABSORB clinical 60 CBLC# 60 investigational pan BCR 60 relapsing multiple sclerosis 60 ecallantide 60 leading oral taxane 60 ThermoDox ® 60 oral picoplatin 60 INSPIRE Trial Phase III 60 teriflunomide 60 ritonavir boosted danoprevir 60 OLpur TM H2H 60 desvenlafaxine 60 custirsen 60 Luveniq 60 unblind 60 Dalbavancin 60 triphendiol 60 mGluR5 negative 60 personalized cellular immunotherapy 60 Prodarsan 60 TKM ApoB 60 Vilazodone 60 EVIZON TM 60 cancer neuroendocrine tumor 60 Loramyc R 60 galiximab 60 REVIVE Diabetes 60 Plenaxis TM 60 vandetanib 60 Xerecept 60 non metastatic osteosarcoma 60 Hepatocellular Carcinoma HCC 60 PEG Interferon lambda 60 valopicitabine NM# 60 naronapride 60 Phase III LibiGel 60 CytoFab 60 multicenter phase 60 TRANSDUR Bupivacaine 60 Anturol ® 60 zanolimumab 60 FACTIVE R gemifloxacin 60 Oncoscience AG 60 dasatinib Sprycel ® 60 Inhalation Solution 60 OZURDEX ® 60 refractory Hodgkin lymphoma 60 OMNARIS Nasal Spray 60 SAR# [004] 60 Diabetic Macular Edema 60 dacetuzumab 60 preclinically 60 dalbavancin 60 OMAPRO ™ 60 Zingo TM 60 Sular formulation 60 sargramostim 60 Tarceva TM 60 Octreolin 60 TRANSFORMS 60 PRE SURGE 60 BrachySil TM 60 POSIDUR TM 60 PA# [002] 60 Daclizumab 60 INT# [002] 60 Syncria 60 Immunotherapeutic 60 LymphoStat B 60 multicenter randomized Phase 60 CHAMPION PCI 60 subcutaneous methylnaltrexone 60 neurogenic orthostatic hypotension 60 Omapro 60 NUEDEXTA 60 ANCHOR trial 60 lorcaserin Phase 60 Acetavance TM 60 AAG geldanamycin analog 60 Insegia 60 XL# SAR# 60 oral treprostinil 60 6R BH4 60 Increlex TM 60 trastuzumab emtansine T DM1 60 regorafenib 60 mitogen activated ERK kinase 60 overactive bladder AA# 60 miconazole Lauriad R 60 vaginally administered lidocaine 60 RE LY 60 Serdaxin ® 60 markets HP Acthar 60 dutogliptin 60 Asentar TM 60 Neo Kidney Augment 60 evaluating carfilzomib 60 biologic therapy 60 Elagolix 60 forodesine hydrochloride 60 IIa trials 60 RHUCIN 60 KIACTA ™ 60 CIMZIA TM certolizumab pegol 60 EDEMA4 60 bortezomib Velcade 60 Mepact 60 arzoxifene 60 Relovair 60 Meets Primary Endpoint 60 CINTREDEKIN BESUDOTOX 60 BioSante LibiGel Phase III 60 post operative ileus 60 Trobalt 60 active comparator 60 BST CarGel R 60 Chrysalin 60 LB# [003] 60 Alocrest 60 omega interferon 60 randomized Phase 60 Bioral Amphotericin B 60 dose dose escalation 60 Zalbin 60 recurrent glioblastoma multiforme 60 Stavzor TM 60 bendamustine 60 BCR ABL inhibitor 60 pharmacokinetics PK 60 Veronate 60 DU #b 60 AGILECT ® 60 elacytarabine 60 multicenter prospective 60 trastuzumab Herceptin R 60 RSD# 60 IRX 2 60 OMAPRO 60 oral mTOR inhibitor 60 Hematide ™ peginesatide 60 refractory CLL 60 linaclotide 60 Huntexil 60 ozarelix 60 unblinded 60 refractory APL 60 subcutaneous RELISTOR 60 SEPET TM 60 Aurexis 60 palifosfamide 60 pegloticase 60 preclinical studies 60 Plecanatide 60 TASKi2 60 PRIMO CABG2 60 CTA# Injection 60 midstage studies 60 Evoltra 60 Cinryze TM 60 FIRAZYR 60 LCP AtorFen 60 MyVax personalized immunotherapy 60 ancrod 60 tafamidis 60 painful diabetic neuropathy 60 CIP TRAMADOL ER 60 Zybrestat 59 BrachySil 59 Onco TCS 59 eculizumab 59 SILENOR ™ 59 MYDICAR 59 IV APAP 59 oral rivaroxaban 59 ROTATEQ 59 BLOOM DM 59 ANYARA 59 INTERCEPT platelets 59 sumatriptan DosePro 59 Topical Interferon Alpha 2b 59 Xcellerated T Cells 59 oral taxane 59 Somatuline R Depot 59 OncoVEX 59 Hyphanox 59 PROPEL trial 59 IMPACT DCM clinical 59 Pivotal Study 59 ulimorelin 59 senicapoc 59 Trizytek 59 multicentre 59 Evoltra TM 59 defensin mimetic antibiotic 59 talactoferrin 59 GRNVAC1 59 zalutumumab 59 bosutinib